New recommendations for contact tracing in tuberculosis: German Central Committee against Tuberculosis Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose;Neue Empfehlungen für die Umgebungsuntersuchungen bei Tuberkulose* 1: Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose

Gesundheitswesen

Volumn 73, Issue 6, 2011, Pages 369-388

  Diel, R ^a   Loytved, G ^a   Nienhaus, A ^b   Castell, S ^a   Detjen, A ^c   Geerdes Fenge, H ^d   Haas, W ^e   Hauer, B ^d   Konigstein B ^a   Maffei, D ^a   Magdorf, K ^f   Priwitzer, M ^a   Zellweger, J P ^g   Loddenkemper, R ^a  

^a Deutsches Zentralkomitee Zur Bekämpfung der Tuberkulose ^*  (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^d ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^e ROBERT KOCH INSTITUTE   (Germany)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g Lungenliga Schweiz   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ARTICLE; CHILD; COMPARATIVE STUDY; CONTACT EXAMINATION; DISEASE TRANSMISSION; GERMANY; HUMAN; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; METHODOLOGY; OPPORTUNISTIC INFECTION; PREDICTIVE VALUE; PRESCHOOL CHILD; RISK FACTOR; TUBERCULIN TEST;

BCG VACCINE; CHILD; CHILD, PRESCHOOL; CONTACT TRACING; GERMANY; HUMANS; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; OPPORTUNISTIC INFECTIONS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TUBERCULIN TEST;

EID: 79959209333     PISSN: 09413790     EISSN: 14394421     Source Type: Journal    
DOI: 10.1055/s-0030-1256574     Document Type: Article

References (119)

1. Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose (DZK). Empfehlungen für die Umgebungsuntersuchungen bei Tuberkulose. Gesundheitswesen 2007 69 488-503
2. RKI. Falldefinitionen des Robert Koch-Instituts zur übermittlung von Erkrankungs- oder Todesfällen und Nachweisen von Krankheitserregern,. Ausgabe 2007
3. Templeton G L., Illing L A., Young L et al. The risk of transmission of Mycobacterium tuberculosis at the bedside and during autopsy. Ann Int Med 1995 122 922-925
4. Riley R L. The contagiosity of tuberculosis. Schweiz Med Wochenschr 1983 113 75-79
5. Diel R, Schneider S, Meywald-Walter K et al. Epidemiology of tuberculosis in Hamburg, Germany: long-term population-based analysis applying classical and molecular epidemiological techniques. J Clin Microbiol 2002 40 532-539 (Pubitemid 34130878)
6. Behr M A., Warren S A., Salamon H et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 1999 353 444-449 (Pubitemid 29067335)
7. Loudon R G., Spohn S K. Cough frequency and infectivity in patients with pulmonary tuberculosis. Am Rev Resp Dis 1969 99 109-111
8. Loudon R G., Roberts R M. Droplet expulsion from the respiratory tract. Am Rev Respir Dis 1966 95 435-442
9. Curtis A B., Ridzon R, Vogel R et al. Extensive transmission of Mycobacterium tuberculosis from a child. N Engl J Med 1999 341 1491-1495 (Pubitemid 29526351)
10. Sultan L, Nyka W, Mills C et al. Tuberculosis disseminators: a study of the variability of aerial infectivity of tuberculosis patients. Am Rev Respir Dis 1960 82 358-369
11. Kenyon T A., Valway S E., Ihle W W. et al. Transmission of multidrug-resistant Mycobacterium tuberculosis during a long airplane flight. N Engl J Med 1996 334 933-938 (Pubitemid 26114158)
12. Behr M A., Hopewell P C., Paz E A. et al. Predictive value of contact investigation for identifying recent transmission of Mycobacterium tuberculosis. Am J Respir Crit Care Med 1998 158 465-469 (Pubitemid 28378174)
13. Diel R, Seidler A, Nienhaus A et al. Occupational risk of tuberculosis transmission in a low incidence area. Resp Res 2005 6 35
14. Veen J. Microepidemics of tuberculosis: the stone-in-the-pond principle. Tuber Lung Dis 1992 73 73-76
15. Khan E A., Starke J R. Diagnosis of tuberculosis in children: increased need for better methods. Emerg Infect Dis 1995 1 115-123
16. Elwood R K., Cook J K., Hernández-Garduño E. Risk of tuberculosis in children from smear-negative source cases. Int J Tuberc Lung Dis 2005 9 49-55 (Pubitemid 40095109)
17. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000 161 S221-S247
18. Keane J, Gershon S, Wise R P. et al. Tuberculosis associated with infliximab, a tumor necrosis -neutralizing agent. N Engl J Med 2001 354 1098-1104
19. Morgenroth K, Schnabel R. Pathogenese und Pathomorphologie der Tuberkulose. In: Konietzko N Loddenkemper R Hrsg. Tuberkulose. Stuttgart Thieme 1999
20. Wallgren A. Time-table of tuberculosis. Tubercle 1948 29 250-253
21. Comstock G, Edwards P. The competing risks for tuberculosis and hepatitis for adult tuberculin reactors. Am Rev Respir Dis 1975 111 5763-577
22. Tufariello J M., Chan J, Flynn J L. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infec Dis 2003 3 578-590 (Pubitemid 37064537)
23. Marks G B., Bai J, Simpson S E. et al. Incidence of tuberculosis among a cohort of tuberculin-positive refugees in Australia: reappraising the estimates of risk. Am J Resp Crit Care Med 2000 162 1851-1854
24. Ferebee S H. Controlled chemoprophylaxis trials in tuberculosis A general review. Adv Tuberc Res 1970 18 28-106
25. Sutherland I. Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli. Adv Tuberc Res 1976 19 1-63
26. Neumann G. Aufgaben des Gesundheitsamtes bei der Tuberkulosebekä mpfung. Öff Gesund-Wes 1985 47 98-100
27. Weis S E., Pogada J M., Yang Z et al. Transmission dynamics of tuberculosis in Tarrant County. Am J Respir Crit Care Med 2002 166 36-42 (Pubitemid 34693960)
28. Small P M., Hopewell P C., Singh S P. et al. The epidemiology of tuberculosis in San Francisco: a population-based study using conventional and molecular methods. N Engl J Med 1994 330 1703-1709
29. Van Soolingen D, Borgdorff M W., de Haas P E. et al. Molecular epidemiology of tuberculosis in The Netherlands: a nationwide survey from 1993 through 1997. J Infect Dis 1999 180 726-736 (Pubitemid 29411359)
30. Alland D, Kalkut G E., Moss A R. et al. Transmission of tuberculosis in New York City: an analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 1994 330 1710-1716
31. Van Deutekom H, Gerritsen J J., van Soolingen D et al. A molecular epidemiological approach to studying the transmission of tuberculosis in Amsterdam. Clin Infect Dis 1997 25 1071-1077 (Pubitemid 27513189)
32. Braden C R., Templeton G L., Cave M D. et al. Interpretation of restriction fragment length polymorphism analysis in M. tuberculosis isolates from a state with a large rural population. J Infect Dis 1997 175 1446-1452 (Pubitemid 27225049)
33. Sebek M. DNA fingerprinting and contact investigation. Int J Tuberc Lung Dis 2000 4 S45-S48 (Pubitemid 30121052)
34. Seidler A, Diel R. Aspekte der beruflichen übertragung der Tuberkulose im Lichte neuer molekularbiologischer Ansätze. In: Nienhaus A Brandenburg S Teschler H Hrsg. Tuberkulose als Berufskrankheit. Landsberg ecomed 2003
35. Robert Koch-Institut. Bericht zur Epidemiologie der Tuberkulose in Deutschland für 2009. Berlin 2011
36. American Thoracic Society (ATS), Centers for Disease Control and Prevention (CDC), American Academy of Pediatrics and Infectious Disease Society of America. Control of tuberculosis in the United States. Am Rev Resp Dis 1992 118 1623-1633
37. British Thoracic and Tuberculosis Association. A study of a standardised contact procedure in tuberculosis. Tubercle 1978 59 245-259
38. Köhler H. übertragung einer Tuberkulose auf dem Genitalwege. Zschr Urol 1973 66 207-209
39. Diel R, Meywald-Walter K, Gottschalk R et al. Ongoing outbreak of tuberculosis in a low-incidence community: a molecular-epidemiological evaluation. Int J Tuberc Lung Dis 2004 8 855-861 (Pubitemid 38937602)
40. Bales S, Baumann H G., Schnitzler N. Kommentar zum Infektionsschutzgesetz IfSG. Köln W. Kohlhammer 2000
41. Erdle H. Das Infektionsschutzgesetz, Kommentar. Landsberg/Lech ecomed 2000
42. Anonymus. Die Tätigkeit des Gesundheitsamtes bei der Tuberkulosefürsorge. VersR 1959 353-355
43. Anonymus. Verordnung über den Schutz vor Schäden durch Röntgenstrahlen (Röntgenverordnung RöV). BGBl I vom 8.1.1987 114-133
44. Anonymus. Verordnung zur änderung der Röntgenverordnung und anderer atomrechtlicher Verordnungen (RöV). BGBl I vom 21.6.2002 1869ff
45. Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose (DZK). Das Strahlenrisiko bei Röntgenuntersuchungen des Thorax. Pneumologie 2001 55 57-71
46. Kaufmann S HE. Die Immunantwort gegen Tuberkulose. In: Konietzko N Loddenkemper R Hrsg. Tuberkulose. Stuttgart Thieme 1999
47. Singh D, Sutton C, Woodcock A. Tuberculin test measurement variability due to the time of reading. Chest 2002 122 1299-1301 (Pubitemid 35339544)
48. Youssef E, Wooltorton E. Serious allergic reactions following tuberculin skin tests. CMAJ 2005 173 34 (Pubitemid 40980937)
49. Menzies D. Interpretation of repeated tuberculin tests. Boosting, conversion and reversion. Am J Respir Crit Care Med 1999 159 15-21 (Pubitemid 29036497)
50. Poulsen A. Some clinical features of tuberculosis. 1. Incubation period. Acta Tuberc Scand 1950 24 311-346
51. Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose (DZK). Richtlinien zur Tuberkulindiagnostik. Dt ärztebl 1996 93 1199-1201
52. Horsburgh C R. Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 2004 350 2060-2079
53. Lange C, Schaberg T, Diel R et al. Aktueller Stand der Tuberkulosediagnostik. DMW 2006 131 341-347
54. Comstock G W. Identification of an effective vaccine against tuberculosis. Am Rev Respir Dis 1988 138 479-480
55. Tissot F, Zanetti G, Francioli P et al. Influence of Bacille Calmette-Guérin vaccination on size of tuberculin skin test reaction: to what size? Clin Inf Dis 2005 40 211-217 (Pubitemid 40110663)
56. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007 146 340-354 Erratum in: Ann Intern Med 2007; 146: 688 (Pubitemid 351650594)
57. Mori T, Sakatani M, Yamagishi F et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004 170 59-64 (Pubitemid 38997752)
58. Diel R, Goletti D, Ferrara G et al. Interferon- release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J 2011 37 88-99
59. Simon K, Gutland M. Die Tuberkulinprobe in der Klinik Dosierung und Wertung. Prax Klin Pneumol 1988 42 423-426
60. Cole S T., Brosch R, Parkhill J et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998 393 537-544 Erratum in: Nature 1998; 396: 190 (Pubitemid 28319235)
61. Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: Part 1. Latent tuberculosis. Expert Rev Mol Diagn 2006 6 413-422 (Pubitemid 44174345)
62. Anibarro L, Trigo M, Villaverde C et al. Interferon- release assays in tuberculosis contacts: is there a window period? Eur Respir J 2011 37 215-217
63. Lee S W., Oh D K., Lee S H. et al. Time interval to conversion of interferon-{gamma} release assay after exposure to tuberculosis. Eur Respir J 2010 Dec 9 [Epub ahead of print]
64. Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest 2010 137 952-968
65. Sester M, Sotgiu G, Lange C et al. Interferon- release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J 2011 37 100-111
66. Hoffmann M, Raven P. The use of Interferon-gamma Release assays in HIV-positive individuals. Eur Infect Dis 2010 4 23-29
67. Pai M, Zwerling A, Menzies D. Systematic review: T-cell based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008 149 177-184
68. Bamford A R., Crook A M., Clark J E. et al. Comparison of Interferon-gamma release assays and Tuberculin Skin Test in predicting active tuberculosis (TB) in children in the UK: a paediatric TB Network Study. Arch Dis Child 2010 95 180-186 [Epub 2009 Oct 8]
69. Bianchi L, Galli L, Moriondo M et al. Interferon-gamma release assay improves the diagnosis of tuberculosis in children. Pediatr Infect Dis J 2009 28 510-514
70. Connell T G., Ritz N, Paxton G A. et al. A three-way comparison of tuberculin skin testing, QuantiFERONTB Gold and T-Spot.TB in children. PLos One 2008 3 e2624
71. Cruz A T., Geltemeyer A M., Starke J R. et al. Comparing the tuberculin skin test and T-SPOT.TB blood test in children. Pediatrics 2011 127 e31-e38 [Epub 2010 Dec 6]
72. Detjen A K., Keil T, Roll S et al. Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis 2007 45 322-328 (Pubitemid 47101028)
73. Kampmann B, Whittaker E, Williams A et al. Interferon-gamma release assays do not identify more children with active TB than TST. Eur Respir J 2009 33 1374-1382
74. Nicol M P., Davies M A., Wood K et al. Comparison of T-SPOT.TB assay and tuberculin skin test for the evaluation of young children at high risk for tuberculosis in a community setting. Pediatrics 2009 123 38-43
75. Bienek D R., Chang C K. Evaluation of an interferon-gamma release assay, T-SPOT.TB, in a population with a low prevalence of tuberculosis. Int J Tuberc Lung Dis 2009 13 1416-1421
76. Wang S H., Powell D A., Nagaraja H N. et al. Evaluation of a modified interferon-gamma release assay for the diagnosis of latent tuberculosis infection in adult and paediatric populations that enables delayed processing. Scand J Infect Dis 2010 42 845-850
77. Aichelburg M C., Rieger A, Breitenecker F et al. Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals. Clin Infect Dis 2009 48 954-962
78. Clark S A., Martin S L., Pozniak A et al. Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease. Clin Exp Immunol 2007 150 238-244 (Pubitemid 47609557)
79. Diel R, Loddenkemper R, Niemann S et al. Negative and positive predictive value of a whole-blood interferon-{gamma} release assay for dveloping active tuberculosis: An update. Am J Respir Crit Care Med 2011 183 88-95
80. Haldar P, Thuraisingham H, Hoskyns W, Woltmann G. Contact screening with single-step TIGRA testing and risk of active TB infection: The Leicester cohort analysis. Thorax 2009 64 (Suppl. 4) A10
81. Kik S V., Franken W P., Mensen M et al. Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts. Eur Respir J 2010 35 1346-1353
82. Diel R, Schaberg T, Loddenkemper R et al. Enhanced cost-benefit analysis of strategies for LTBI screening and INH chemoprevention in Germany. Respir Med 2009 103 1838-1853
83. Diel R, Wrighton-Smith P, Zellweger J P. Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis. Eur Respir J 2007 30 321-332 (Pubitemid 47194185)
84. Rangaka M X., Wilkinson K, Seldon R et al. The effect of HIV-1 infection on T cell based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med 2007 175 514-529
85. Liebeschuetz S, Bamber S, Ewer K et al. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 2004 364 2196-2039
86. Passalent L, Khan K, Richardson R. Detecting latent tuberculosis infection in hemodialysis patients: A head-to-head comparison of the T-SPOT. TB test, tuberculin skin test, and an expert physician panel. Clin J Am Soc Nephr 2007 2 68-73
87. Diel R, Hauer B, Loddenkemper R et al. Empfehlungen für das Tuberkulosescreening vor Gabe von TNF - Inhibitoren bei rheumatischen Erkrankungen. Pneumologie 2009 63 329-334 und Z Rheumatol 2009; 68: 411416
88. Meyer M, Clarke P, ORegan A W. Utility of the lateral chest radiograph in the evaluation of patients with a positive tuberculin skin test result. Chest 2003 124 1824-1827 (Pubitemid 37433579)
89. Tuberculosis coalition for technical assistance. International standards for tuberculosis care (ISTC). The Hague: Tuberculosis coalition for technical assistance. 2006
90. National Institute for Clinical Excellence (NICE). Tuberculosis. National clinical guideline for diagnosis, management, prevention, and control. March 2006 www.nice.org.uk Stand: 1.4.2011
91. Centers for Disease Control and Prevention. Guidelines for the investigation of contacts of persons with infectious tuberculosis: Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR 2005 54 (RR-15) 1-37
92. World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children. Geneva 2006 (WHO/HTM/TB/2006.371)
93. Magdorf K, Fehn T, Griese M et al. Tuberkulose und nichttuberkulöse mykobakterielle Krankheiten. In: Deutsche Gesellschaft für pädiatrische Infektiologie e.V. (DGPI) Hrsg. DGPI Handbuch: Infektionen bei Kindern und Jugendlichen. Stuttgart Georg Thieme 2009
94. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep 2000 49 (RR-6) 1-51
95. Schaberg T, Castell S, Dalhoff K et al. Empfehlungen zur medikamentösen Therapie der Tuberkulose im Erwachsenen- und Kindesalter. Pneumologie 2011 [in Vorbereitung]
96. Nardell E A., Wallis R S. Here today gone tomorrow: the case for transient acute tuberculosis infection. Am J Respir Crit Care Med 2006 174 734-735 (Pubitemid 44511653)
97. Centers for Disease Control and Prevention. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection United States, 2010. MMWR Recomm Rep 2010 59 (RR-5) 1-25
98. Perry S, Parsonnet J. Commentary: H. pylori infection in early life and the problem of imperfect tests. Int J Epidemiol 2005 34 1356-1358 (Pubitemid 41819544)
99. Perry S, Sanchez L, Yang S et al. Reproducibility of QuantiFERON-TB gold in-tube assay. Clin Vaccine Immunol 2008 15 425-432 (Pubitemid 351967072)
100. Ewer K, Millington K A., Deeks J J. et al. Dynamic antigen-specific T cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med 2006 174 831-839 (Pubitemid 44511666)
101. Friedman L N., Nash E R., Bryant J et al. High rate of negative results of tuberculin and QuantiFERON tests among individuals with a history of positive skin test results. Infect Control Hosp Epidemiol 2006 27 436-441 (Pubitemid 43835523)
102. Shams H, Weis S E., Klucar P et al. Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection. Am J Respir Crit Care Med 2005 172 1161-1168 (Pubitemid 43066653)
103. Loytved G. Umgebungsuntersuchungen in Schulen. Tuberkulintestung am Friedrich Dessauer Gymnasium Aschaffenburg. Vortragsmanuskript vom 17.11.2004.
104. RKI. Erfahrungsbericht: Tuberkulose in einer Klasse einer Mittelschule. Epid Bull 2004 44 377
105. RKI. Hinweise für ärzte, Leitungen von Gemeinschaftseinrichtungen und Gesundheitsämter zur Wiederzulassung in Schulen und sonstigen Gemeinschaftseinrichtungen. Aktualisierte Fassung vom 25. Juli 2006. Erstveröffentlichung im Bundesgesundhbl Gesundhforsch Gesundhschutz 2001 44 830-841
106. RKI. Tuberkulose in großen Gemeinschaften. Beispiele der Handhabung von Umgebungsuntersuchungen. Epid Bull 2001 41 25-29
107. Verordnung zur Umsetzung von EG-Richtlinien über den Schutz der Beschäftigten gegen Gefährdung durch biologische Arbeitsstoffe bei der Arbeit (BioStoffV) vom 27.01.1999. BGBl I 50-60
108. Kollecker S. Zur Frage der Anzeigepflicht von ärzten bei der Tuberkulinkonversion. In: Nienhaus A Brandenburg S Teschler H Hrsg. Tuberkulose als Berufskrankheit. Landsberg ecomed 2003
109. Nienhaus A, Loddenkemper R, Hauer B et al. Latente Tuberkulose- Infektionen im Gesundheitswesen Evaluation des Interferon- Release Assay. Pneumologie 2007 61 219-222
110. Torres Costa J, Sá R, Cardoso M J. et al. Tuberculosis screening in Portuguese healthcare workers using the Tuberculin Skin Test and the Interferon- release assay. Eur Resp J 2009 34 1423-1428
111. MiQ. Mikrobiologisch-infektiologische Qualitätsstandards (MiQ) 5-Tuberkulose, Mykobakteriose. München Elsevier 2010
112. RKI. Zu einer ausgedehnten Tuberkulosehäufung im Wohn- und Arbeitsumfeld von Behinderten. Epid Bull 2004 44 378-379
113. Kendig N. Tuberculosis control in prisons. Int J Tuberc Lung Dis 1998 2 S57-S63
114. World Health Organization. Tuberculosis and air travel. Guidelines for prevention and control. 3rd edition Geneva 2008 (WHO/HTM/TB/2009.399)
115. ECDC technical report. Risk assessment guidelines for infectious diseases transmitted on aircraft. Stockholm 2009 http://www.ecdc.europa.eu/en/ publications/Publications/0906-TER-Risk-Assessment-Guidelines-for-Infectious- Diseases-Transmitted-on-Aircraft.pdf Stand: 1.4.2011
116. Gronauer W, Pregler M, Wolf P. Bemerkenswerte Tuberkulose-Kleinepidemien 2001/2002 in zwei bayerischen Regierungsbezirken. Pneumologie 2004 58 9-16 (Pubitemid 38197778)
117. Hauer B, Kunitz F, Sagebiel D et al. Untersuchungen zur Tuberkulose in Deutschland: Molekulare Epidemiologie, Resistenzsituation und Behandlung (überarbeiteter Abschlussbericht zur DZK-Studie). Berlin DZK 2006
118. Malakmadze N, González I M., Oemig T et al. Unsuspected recent transmission of tuberculosis among high-risk groups: implications of universal tuberculosis genotyping in its detection. Clin Infect Dis 2005 40 366-373 (Pubitemid 40216503)
119. De Vries G, van Hest R A., Burdo C C. et al. A Mycobacterium tuberculosis cluster demonstrating the use of genotyping in urban tuberculosis control. BMC Infect Dis 2009 9 151